{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:10:41Z","timestamp":1792102241371,"version":"4.4.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T00:00:00Z","timestamp":1701043200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","ejinme.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ejim.2023.11.017","type":"journal-article","created":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T12:57:26Z","timestamp":1701262646000},"page":"48-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Event rates and risk factors for venous thromboembolism and major bleeding in a population of hospitalized adult patients with acute medical illness receiving enoxaparin thromboprophylaxis"],"prefix":"10.1016","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9253-248X","authenticated-orcid":false,"given":"Gr\u00e9goire","family":"Le Gal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Agnelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Darius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan R","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek","family":"Owaidah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Thereza","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenguo","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9832-0904","authenticated-orcid":false,"given":"Irfan","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmina","family":"Djoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6334-8034","authenticated-orcid":false,"given":"Ekaterina","family":"Ponomareva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander T.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ejim.2023.11.017_bib0001","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1161\/ATVBAHA.114.304488","article-title":"ISTH steering committee for world thrombosis day. Thrombosis: a major contributor to global disease burden","volume":"34","author":"Raskob","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10294","key":"10.1016\/j.ejim.2023.11.017_bib0002","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(20)32658-1","article-title":"Venous thromboembolism","volume":"398","author":"Khan","year":"2021","journal-title":"The Lancet"},{"issue":"24","key":"10.1016\/j.ejim.2023.11.017_bib0003","doi-asserted-by":"crossref","first-page":"e914","DOI":"10.1161\/CIR.0000000000000769","article-title":"American Heart Association Advocacy Coordinating Committee. Call to action to prevent venous thromboembolism in hospitalized patients: a policy statement From the American Heart Association","volume":"141","author":"Henke","year":"2020","journal-title":"Circulation."},{"issue":"10063","key":"10.1016\/j.ejim.2023.11.017_bib0004","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1016\/S0140-6736(16)30514-1","article-title":"Deep vein thrombosis and pulmonary embolism","volume":"388","author":"Di Nisio","year":"2016","journal-title":"The Lancet"},{"issue":"22","key":"10.1016\/j.ejim.2023.11.017_bib0005","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1182\/bloodadvances.2018022954","article-title":"American society of hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients","volume":"2","author":"Sch\u00fcnemann","year":"2018","journal-title":"Blood advances"},{"issue":"2","key":"10.1016\/j.ejim.2023.11.017_bib0006","doi-asserted-by":"crossref","first-page":"e195S","DOI":"10.1378\/chest.11-2296","article-title":"Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis: American college of chest physicians evidence-based clinical practice guidelines","volume":"141","author":"Kahn","year":"2012","journal-title":"Chest."},{"key":"10.1016\/j.ejim.2023.11.017_bib0007","first-page":"279","article-title":"Clinical guidelines committee of the American College of P","volume":"2","author":"Qaseem","year":"2013","journal-title":"Oral pharmacologic treatment of type"},{"issue":"20","key":"10.1016\/j.ejim.2023.11.017_bib0008","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1182\/blood.2019003603","article-title":"Prognostic factors for VTE and bleeding in hospitalized medical patients: a systematic review and meta-analysis","volume":"135","author":"Darzi","year":"2020","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.ejim.2023.11.017_bib0009","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJM199909093411103","article-title":"A comparison of enoxaparin with placebo for the prevention of VTE in acutely ill medical patients. Prophylaxis in Medical Patients Study Group","volume":"341","author":"Samama","year":"1999","journal-title":"N Engl J Med"},{"issue":"7537","key":"10.1016\/j.ejim.2023.11.017_bib0010","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/bmj.38733.466748.7C","article-title":"Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial","volume":"332","author":"Cohen Alexander","year":"2006","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.ejim.2023.11.017_bib0011","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/01.CIR.0000138928.83266.24","article-title":"Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients","volume":"110","author":"Leizorovicz","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2023.11.017_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjmed.2019.12.001","article-title":"Extended venous thromboembolism prophylaxis in medically ill patients: an NATF anticoagulation action initiative","volume":"133","author":"Barkoudah","year":"2020","journal-title":"Am J Med"},{"issue":"19","key":"10.1016\/j.ejim.2023.11.017_bib0013","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.1182\/bloodadvances.2020002482","article-title":"Risk-assessment models for VTE and bleeding in hospitalized medical patients: an overview of systematic reviews","volume":"4","author":"Darzi","year":"2020","journal-title":"Blood Adv"},{"issue":"9","key":"10.1016\/j.ejim.2023.11.017_bib0014","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.022198","article-title":"Event rates and risk factors for recurrent cardiovascular events and mortality in a contemporary post acute coronary syndrome population representing 239 234 patients during 2005 to 2018 in the United States","volume":"11","author":"Steen","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"06","key":"10.1016\/j.ejim.2023.11.017_bib0015","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1055\/s-0040-1710326","article-title":"Prevention of venous thromboembolism in hospitalized medically ill patients: a US perspective","volume":"120","author":"Spyropoulos","year":"2020","journal-title":"Thromb Haemost"},{"issue":"11","key":"10.1016\/j.ejim.2023.11.017_bib0016","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1111\/j.1538-7836.2010.04044.x","article-title":"A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua prediction score","volume":"8","author":"Barbar","year":"2010","journal-title":"J Thrombosis Haemostas"},{"issue":"3","key":"10.1016\/j.ejim.2023.11.017_bib0017","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1378\/chest.10-1944","article-title":"Predictive and associative models to identify hospitalized medical patients at risk for VTE","volume":"140","author":"Spyropoulos","year":"2011","journal-title":"Chest."},{"issue":"1","key":"10.1016\/j.ejim.2023.11.017_bib0018","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1378\/chest.09-3081","article-title":"Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators","volume":"139","author":"Decousus","year":"2011","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ejim.2023.11.017_bib0019","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11239-022-02757-8","article-title":"External validation of the ADA score for predicting thrombosis among acutely ill hospitalized medical patients from the APEX Trial","volume":"55","author":"Chi","year":"2023","journal-title":"J Thromb Thrombolysis"},{"issue":"09","key":"10.1016\/j.ejim.2023.11.017_bib0020","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1160\/TH16-01-0003","article-title":"External validation of the IMPROVE Bleeding Risk Assessment Model in medical patients","volume":"116","author":"Rosenberg","year":"2016","journal-title":"Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.ejim.2023.11.017_bib0021","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/jth.14796","article-title":"Validation of risk assessment models predicting venous thromboembolism in acutely ill medical inpatients: a cohort study","volume":"18","author":"Moumneh","year":"2020","journal-title":"J Thrombosis Haemostasis"},{"issue":"9","key":"10.1016\/j.ejim.2023.11.017_bib0022","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.amjmed.2016.03.031","article-title":"Validation of risk assessment models of venous thromboembolism in hospitalized medical patients","volume":"129","author":"Greene","year":"2016","journal-title":"Am J Med"},{"issue":"9","key":"10.1016\/j.ejim.2023.11.017_bib0023","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/archinte.164.9.963","article-title":"Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study","volume":"164","author":"Alikhan","year":"2004","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.ejim.2023.11.017_bib0024","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12959-023-00450-1","article-title":"Comparison of VTE risk scores in guidelines for VTE diagnosis in nonsurgical hospitalized patients with suspected VTE","volume":"21","author":"Xiong","year":"2023","journal-title":"Thromb J"},{"key":"10.1016\/j.ejim.2023.11.017_bib0025","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s11739-013-0944-8","article-title":"Prophylaxis of venous thromboembolism in elderly patients with multimorbidity","volume":"8","author":"Marcucci","year":"2013","journal-title":"Intern Emerg Med"},{"issue":"1","key":"10.1016\/j.ejim.2023.11.017_bib0026","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11739-022-03121-7","article-title":"Prescription appropriateness of anticoagulant drugs for prophylaxis of venous thromboembolism in hospitalized multimorbid older patients","volume":"18","author":"Rossio","year":"2023","journal-title":"Intern Emerg Med"},{"issue":"1","key":"10.1016\/j.ejim.2023.11.017_bib0027","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12959-022-00433-8","article-title":"Asymptomatic and symptomatic deep venous thrombosis in hospitalized acutely ill medical patients: risk factors and therapeutic implications","volume":"20","author":"Loffredo","year":"2022","journal-title":"Thromb J"},{"issue":"1","key":"10.1016\/j.ejim.2023.11.017_bib0028","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mayocp.2018.07.020","article-title":"Low rate of Intrahospital deep venous thrombosis in acutely Ill medical patients: results from the AURELIO study","volume":"94","author":"Loffredo","year":"2019","journal-title":"Mayo Clin Proc"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620523004144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620523004144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T03:57:43Z","timestamp":1737604663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620523004144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":28,"alternative-id":["S0953620523004144"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2023.11.017","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Event rates and risk factors for venous thromboembolism and major bleeding in a population of hospitalized adult patients with acute medical illness receiving enoxaparin thromboprophylaxis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2023.11.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.","name":"copyright","label":"Copyright"}]}}